Loading…
New: tenders and results on WhatsApp
New: Find tenders, results and companies on WhatsApp, by text or voice note
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Offered Item | Amount | Rank | Status |
|---|---|---|---|---|---|
| 1 | TAKEDA BIOPHARMACEUTICALS INDIA PRIVATE LIMITEDInferred winner L1₹50.0 LQualified Make: ELAPRASE
Model: Idursulfase (r-DNA origin) -6mg/3mL
Title: Inj idursulfase 6mg per ml 6TH FLOOR BUILDING NO 8 TOWER C DLF CYBER CITY PHASE II MOTI NAGAR GURGAON WEST DELHI DELHI 122002 | GURUGRAM | HARYANA | 122002 | Make: ELAPRASE
Model: Idursulfase (r-DNA origin) -6mg/3mL
Title: Inj idursulfase 6mg per ml | L1 | Qualified MII |
Tender Value
Refer Docs
EMD Value
₹25,000
Closing Date
15 Jan 2025, 11:00 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Inj idursulfase 6mg per ml
7191528
GEM/2024/B/5655331
Two Packet Bid
Inj idursulfase 6mg per ml
30 days
Dehradun, Uttarakhand
Total value wise evaluation
PRODUCT_CUSTOM
5 documents required · 5 mandatory
₹25,000
25 Dec 2024
25 Dec 2024
15 Jan 2025
Inj idursulfase 6mg per ml
inj idursulfase 6mg per ml
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7191528.pdf
GEM_BID
spf_2024-11-26-18-23-54_235f762fd13b0ec7ba5f5be0c686e166.pdf
SPECIFICATION
Undertking_0b471c64-3b0c-47fc-8faf1732676144640_ankitdangi@1234.docx
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .